CRIS Current Research Information System

VITALI, BEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.046
NA - Nord America 14.463
AS - Asia 12.735
AF - Africa 947
Continente sconosciuto - Info sul continente non disponibili 844
SA - Sud America 675
OC - Oceania 34
Totale 48.744
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.125
IT - Italia 11.207
CN - Cina 3.320
SG - Singapore 3.254
VN - Vietnam 2.742
GB - Regno Unito 2.139
DE - Germania 1.217
HK - Hong Kong 939
SE - Svezia 912
FR - Francia 733
IN - India 630
NL - Olanda 576
BR - Brasile 480
RU - Federazione Russa 447
BD - Bangladesh 404
UA - Ucraina 385
IE - Irlanda 302
KR - Corea 256
JP - Giappone 246
CI - Costa d'Avorio 227
ZA - Sudafrica 224
CA - Canada 188
PK - Pakistan 171
FI - Finlandia 166
TG - Togo 144
CH - Svizzera 124
EE - Estonia 113
ID - Indonesia 108
PL - Polonia 101
SC - Seychelles 95
NG - Nigeria 93
BE - Belgio 90
AR - Argentina 87
ES - Italia 82
TR - Turchia 79
PH - Filippine 75
BG - Bulgaria 71
IR - Iran 70
TH - Thailandia 68
JO - Giordania 66
GR - Grecia 62
TW - Taiwan 59
MX - Messico 57
IQ - Iraq 55
HR - Croazia 54
EG - Egitto 53
AT - Austria 41
DZ - Algeria 37
RO - Romania 36
MY - Malesia 32
SA - Arabia Saudita 31
CL - Cile 29
UZ - Uzbekistan 28
AU - Australia 27
JM - Giamaica 23
PT - Portogallo 23
DK - Danimarca 21
CO - Colombia 18
CZ - Repubblica Ceca 18
LB - Libano 18
SM - San Marino 18
MA - Marocco 17
LT - Lituania 15
PE - Perù 15
RS - Serbia 15
SK - Slovacchia (Repubblica Slovacca) 14
NO - Norvegia 13
EC - Ecuador 12
VE - Venezuela 12
AL - Albania 10
CR - Costa Rica 10
HU - Ungheria 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
DO - Repubblica Dominicana 9
IL - Israele 9
TN - Tunisia 9
GH - Ghana 8
KZ - Kazakistan 8
ET - Etiopia 7
KE - Kenya 7
NP - Nepal 7
NZ - Nuova Zelanda 7
PY - Paraguay 7
SI - Slovenia 7
BB - Barbados 6
OM - Oman 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
AZ - Azerbaigian 5
BA - Bosnia-Erzegovina 5
HN - Honduras 5
NI - Nicaragua 5
PS - Palestinian Territory 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
BZ - Belize 4
CM - Camerun 4
GT - Guatemala 4
Totale 47.818
Salva come PNG Salva come JPEG
Città #
Singapore 2.219
Southend 1.762
Ashburn 1.541
Bologna 989
San Jose 901
Hong Kong 859
Chandler 817
Milan 809
Fairfield 759
Rome 745
Ho Chi Minh City 619
Santa Clara 579
Hefei 548
Hanoi 530
Council Bluffs 436
Wilmington 425
Beijing 401
Seattle 390
Ann Arbor 384
Princeton 379
Houston 369
Woodbridge 364
Dallas 358
Los Angeles 335
Boardman 310
Naples 297
Dublin 289
Cambridge 286
New York 285
Frankfurt am Main 280
Abidjan 227
Seoul 222
Dong Ket 218
Turin 214
Florence 208
Lauterbourg 206
Jacksonville 196
Padova 192
Tokyo 184
Nanjing 179
Westminster 156
Lomé 144
Berlin 142
Buffalo 139
Helsinki 121
Bari 113
Modena 108
Catania 105
Jinan 102
Da Nang 97
Palermo 94
Redmond 92
Shanghai 88
Medford 86
Cesena 85
Saint Petersburg 85
Guangzhou 84
Rimini 82
Shenyang 80
São Paulo 79
Haiphong 78
Chicago 74
Redondo Beach 74
Lahore 73
Abeokuta 72
Orem 71
Bengaluru 70
San Diego 68
Verona 68
Phoenix 67
Sofia 67
Dearborn 66
Nanchang 66
Tianjin 65
Amman 64
San Francisco 64
Munich 62
Changsha 60
Johannesburg 59
London 58
Amsterdam 57
Hebei 56
Falls Church 55
Genoa 55
Bern 54
Pescara 54
Atlanta 53
Brussels 53
Denver 52
Jakarta 52
Perugia 50
Gujranwala 49
Montreal 49
Toronto 49
Brooklyn 48
Redwood City 48
Padua 46
Parma 46
Cagliari 45
Mülheim 45
Totale 25.755
Salva come PNG Salva come JPEG
Nome #
VSL#3 in gravidanza: impatto sul microbiota e sulla risposta immune vaginale 7.408
In vitro anti-Candida activity of a Spirulina platensis extract: a new approach for the treatment of fungal infections? 845
Accuratezza della spettrometria di massa MALDI-TOF nell’identificazione di specie di lattobacilli 766
Lactobacillus Biofilms Influence Anti-Candida Activity 748
STUDIO IN VITRO DELL’ATTIVITA’ ANTI-FUNGINA DI UN ESTRATTO DI SPIRULINA PLATENSIS: UN NUOVO APPROCCIO PER IL TRATTAMENTO DELLE CANDIDOSI MUCO-CUTANEE? 708
NUOVI APPROCCI PER L’IDENTIFICAZIONE DI SPECIE DI LATTOBACILLI: RUOLO DELLA SPETTROMETRIA DI MASSA MALDI-TOF E DELLA METABOLOMICA 505
BIFIDOBACTERIUM BREVE BC104: ORALLY ADMINISTERED VAGINAL PROBIOTIC FOR PREVENTING GENITAL AND URINARY TRACT INFECTIONS 417
Development of a Fermented Milk Designed for Women's Well-Being Containing an Exopolysaccharides-Producing Starter Culture and a Functional Vaginal Strain 377
MICROBIOTA VAGINALE IN CORSO DI INFEZIONI DEL TRATTO GENITALE 361
Inserti vaginali mucoadesivi costituiti da complessi di chitosano e alginato per il rilascio locale di clorexidina digluconato 325
Identification of vaginal bacteria 310
Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study 309
Isolation of vaginal lactobacilli and characterization of anti-candida activity 308
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells. 295
Impact of fermented soy beverages containing selected vaginal probiotics on the in vitro fecal microbiota of post-menopausal women 289
Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis 289
Development and characterization of fermented soy beverages containing encapsulated or non-encapsulated vaginal probiotics 284
Azithromycin-loaded liposomes and niosomes for the treatment of skin infections: influence of excipients and preparative methods on the functional properties 279
Drug-in-cyclodextrin-in-polymeric nanoparticles: A promising strategy for rifampicin administration 276
In vitro activity of Spirulina platensis water extract against different Candida species isolated from vulvo-vaginal candidiasis cases. 268
Antioxidant and Functional Features of Pre-Fermented Ingredients Obtained by the Fermentation of Milling By-Products 260
Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion 254
Genotypic and phenotypic characterization of Lactobacillus strains with antipathogenic activities 253
An in vitro evaluation of the effect of probiotics and prebiotics on the metabolic profile of human microbiota 250
Spanish Broom (Spartium junceum L.) fibers impregnated with vancomycin-loaded chitosan nanoparticles as new antibacterial wound dressing: Preparation, characterization and antibacterial activity 249
Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models 245
Development of azithromycin-loaded microemulsions for the treatment of skin infections 240
Vaginal Lactobacillus gasseri biosurfactant: a novel bio- and eco-compatible anti-Candida agent 238
Diversity of vaginal microbiome and metabolome during genital infections 232
Determination of antibacterial and technological properties of vaginal lactobacilli for their potential application in dairy products 230
Characterization and Heterologous Expression of the Oxalyl Coenzyme A Decarboxylase Gene from Bifidobacterium lactis 229
Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains 226
Lactobacilli extracellular vesicles: potential postbiotics to support the vaginal microbiota homeostasis 224
Designing fermented milk with targeted probiotics: a step toward female-focused functional foods 224
Design and validation of a DNA-microarray for phylogenetic analysis of bacterial communities in different oral samples and dental implants 222
Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms 220
VAGINAL MICROBIOME FOR THE PRESERVATION OF WOMEN’S HEALTH USING FOOD STRATEGY 220
Investigation on the effects of antimicrobial imidazo[2,1-b]thiazole derivatives on the genitourinary microflora 219
Identification method based on PCR combined with automated ribotyping for tracking probiotic Lactobacillus strains colonizing the human gut and vagina 216
Biosurfactant for solubilization and skin permeation enhancement of hydrocortisone 216
Computer vision approach for the determination of microbial concentration and growth kinetics using a low cost sensor system 214
Evaluation of the rrn operon copy number in Bifidobacterium using real-time PCR 213
High-dose probiotics for the treatment of active pouchitis 213
Anti-bacterial activity of vaginal lactobacilli against Chlamydia trachomatis 213
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali 212
Azithromycin-loaded vesicles for the treatment of skin infections: a comparative study of different formulations 211
Novel probiotic candidates for humans isolated from raw fruits and vegetables 210
Rifaximin modulates the colonic microbiota of patients with Crohn’s disease: an in vitro approach using a continuous culture colonic model system 209
Lactobacilli cell-free supernatants: Potential green and natural enhancers for nose-to-brain delivery of small hydrophilic molecules 208
Biotechnological Valorization of Brewer's Spent Grains and Grape Pomace to Obtain Functional Ingredients for Food Formulations 207
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 207
Chitosan/alginate complexes for vaginal delivery of chlorhexidine digluconate 207
Insight into phenotypic and genotypic differences between vaginal Lactobacillus crispatus BC5 and Lactobacillus gasseri BC12 to unravel nutritional and stress factors influencing their metabolic activity 206
Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 205
Orange Peel Lactiplantibacillus plantarum: Development of A Mucoadhesive Nasal Spray with Antimicrobial and Anti-Inflammatory Activity 205
Development and Characterization of Azithromycin-Loaded Microemulsions: A Promising Tool for the Treatment of Bacterial Skin Infections 202
New hybrids with 2-aminobenzothiazole and azelayl scaffolds: Synthesis, molecular docking and biological evaluation 202
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 201
Novel mixed vesicles containing lactobacilli biosurfactants for vaginal delivery of econazole nitrate 201
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 200
OralArray: a new phylogenetic DNA-microarray to characterize the oral microbiota 199
Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion 198
Anti-candida activity of hyaluronic acid combined with lactobacillus crispatus lyophilised supernatant: A new antifungal strategy 194
Bacterial concentration detection using a portable embedded sensor system for environmental monitoring 192
Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by 1H Nuclear Magnetic Resonance spectroscopy 191
In-vitro effect of vaginal lactobacilli against group B Streptococcus 190
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections 189
Mucoadhesive chitosan/gelatin films for buccal delivery of propranolol hydrochloride 189
Innovative Fermented Milk Product Enriched with Vaginal Probiotics for Women’s Health 188
Vaginal Lactobacillus Impair Candida Dimorphic Switching and Biofilm Formation 187
Association of mucoadhesive polymeric matrices and liposomes for local delivery of miconazole: A new approach for the treatment of oral candidiasis 186
Studio in vitro dell’attività antimicrobica di lattobacilli vaginali nei confronti di Chlamydia trachomatis. 185
Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system-authors' response 183
Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis 182
Real-time PCR quantification of bacterial adhesion to Caco-2 cells: Competition between bifidobacteria and enteropathogens 181
Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections 181
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 179
Method for diagnosis vaginal infections 178
A proteomic view of Bifidobacterium infantis generated by multi-dimensional chromatography coupled with tandem mass spectrometry 178
Vaginal lactobacillus inhibits HIV-1 replication in human tissues ex vivo 176
Electrical Impedance Spectroscopy (EIS) characterization of saline solutions with a low-cost portable measurement system 176
Human Breast Milk: A Source of Potential Probiotic Candidates 175
Limosilactobacillus vaginalis Exerts Bifidogenic Effects: A Novel Postbiotic Strategy for Infant Prebiotic Supplementation 174
Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis. 174
Evaluation of the fate of Lactobacillus crispatus BC4, carried in Squacquerone cheese, throughout the simulator of the human intestinal microbial ecosystem (SHIME) 174
Approcci innovativi per l’identificazione di specie di lattobacilli: studio dei metaboliti mediante spettrometria di risonanza magnetica (1H-RMN) 173
Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing 173
Vaginal Lactobacilli Reduce Neisseria gonorrhoeae Viability through Multiple Strategies: An in Vitro Study. 173
Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota 170
Development of microparticulate systems for intestinal delivery of Lactobacillus acidophilus and Bifidobacterium lactis 170
Isolation and characterization of biosurfactants produced by Lactobacillus gasseri of vaginal origin 170
Metabolic profiling of Candida clinical isolates of different species and infection sources 170
Bifidobacterium lactis Enolase, surface localization and mechanism of interaction with human Plasminogen 169
Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real time PCR study 168
Biosurfactant loaded vesicles for the local treatment of Staphylococcus aureus skin infections 168
High taxonomic level fingerprint of the human intestinal microbiota by Ligase Detection Reaction - Universal Array approach. 167
Surfactant-enriched liposomes to enhance azithromycin efficacy in Chlamydia trachomatis infections 167
Mucoadhesive Buccal Films for Local Delivery of Lactobacillus brevis 166
Polymer–lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate 165
Correlation of Atopobium vaginae amount with bacterial vaginosis markers 165
Totale 31.313
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.767
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.767
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.748 0 194 237 241 434 253 201 307 200 312 769 600
2022/20235.233 492 619 271 542 391 417 289 334 801 284 446 347
2023/20243.488 250 348 273 319 314 526 228 202 204 337 237 250
2024/20258.160 446 942 817 661 1.014 534 851 470 338 495 466 1.126
2025/202616.800 1.248 1.478 1.331 1.112 1.531 868 1.977 681 2.577 1.325 1.659 1.013
2026/20271.763 1.066 697 0 0 0 0 0 0 0 0 0 0
Totale 48.744